Regencell Bioscience
(NASDAQ:RGC)
$5.10
-0.25[-4.67%]
At close: Apr 23
$5.10
0[0.00%]
After Hours: 7:57PM EDT

Regencell Bioscience Stock (NASDAQ:RGC), Earnings Estimates, EPS, and Revenue

Regencell Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Jun 15
EPS
$-0.250
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
–

Analyze the earnings history of Regencell Bioscience using advanced sorting and filters.

Date
▲▼
time
▲▼
ticker
▲▼
Quarter
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Get Alert
06/13/2024PMRGCH1-$0.25———$0.00———Get Alert
05/10/2024AMRGCFY-$0.58———$0.00———Get Alert
06/15/2023PMRGCH1-$0.29—-$0.25—$0.00—$0.00—Get Alert
10/31/2022PMRGCFY-$0.13—-$0.58—$0.00—$0.00—Get Alert

FAQ

Q

When is Regencell Bioscience (NASDAQ:RGC) reporting earnings?

A

Regencell Bioscience (RGC) is scheduled to report earnings on June 13, 2024. The last reported earnings were for reported on June 15, 2023 for H1.

Q

What were the latest earnings per share (EPS) for Regencell Bioscience (NASDAQ:RGC)?

A

The Actual EPS was $-0.25, which missed the estimate of $0.00.

Q

What were Regencell Bioscience’s (NASDAQ:RGC) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch